Published in Radiother Oncol on June 03, 2014
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT). J Cancer Res Clin Oncol (2015) 0.89
Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients. Radiother Oncol (2015) 0.83
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World J Hepatol (2015) 0.79
Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study. Radiother Oncol (2016) 0.78
Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol (2016) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions. Front Oncol (2016) 0.76
Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions. J Korean Med Sci (2015) 0.76
Liver-Directed Radiotherapy for Hepatocellular Carcinoma. Liver Cancer (2016) 0.76
Clinical research on alternating hyperfraction radiotherapy for massive hepatocellular carcinoma. Oncol Lett (2015) 0.75
Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. Cancer Sci (2016) 0.75
Radiation therapy for hepatobiliary malignancies. J Gastrointest Oncol (2017) 0.75
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma. Radiat Oncol (2017) 0.75